that it falsely markets its compounded tirzepatide as personalized or patient-specific when, Lilly says, the products are really mass-produced rather than genuinely tailored
Now, hundreds of lawsuits are moving forward against Novo Nordisk, alleging the company failed to warn patients about devastating side effects that can permanently damage your digestive system and vision
GLP-1 medications are not controlled substances, which works in your favor
If it is significantly past BUD, was subject to temperature excursions, or shows any visual changes, discard it
prescription or medical records showing your GLP-1 treatment
The doses in compounded combinations may not provide adequate amounts for someone with surgical absorption limitations